Ping Ye Selected Research

Insulin-Like Growth Factor I (IGF-1)

1/2013	Astrocyte-Specific Overexpression of Insulin-Like Growth Factor-1 Protects Hippocampal Neurons and Reduces Behavioral Deficits following Traumatic Brain Injury in Mice.
12/2008	IGF-I improved bone mineral density and body composition of weaver mutant mice.
3/2007	Insulin-like growth factor-I ameliorates demyelination induced by tumor necrosis factor-alpha in transgenic mice.
3/2007	Lack of spontaneous ocular neovascularization and attenuated laser-induced choroidal neovascularization in IGF-I overexpression transgenic mice.
5/2005	Insulin-like growth factor-I protects granule neurons from apoptosis and improves ataxia in weaver mice.
11/2004	Astrocyte-specific overexpression of insulin-like growth factor-I promotes brain overgrowth and glial fibrillary acidic protein expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ping Ye Research Topics

Disease

21	Inflammation (Inflammations) 04/2022 - 12/2004
19	Neoplasms (Cancer) 01/2022 - 12/2006
15	Infections 09/2019 - 02/2003
13	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 02/2005
13	Hypertension (High Blood Pressure) 01/2020 - 12/2003
12	Cardiomegaly (Heart Hypertrophy) 01/2021 - 12/2003
11	Hypertrophy 01/2021 - 02/2005
11	Heart Failure 10/2020 - 10/2012
10	Myocardial Infarction 01/2018 - 07/2005
9	Dyslipidemias (Dyslipidemia) 12/2017 - 06/2003
8	COVID-19 09/2021 - 01/2020
8	Fibrosis (Cirrhosis) 01/2021 - 10/2006
7	Chronic Renal Insufficiency 01/2022 - 01/2013
7	Reperfusion Injury 01/2021 - 01/2007
7	Type 2 Diabetes Mellitus (MODY) 10/2020 - 01/2014
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 10/2005
6	Insulin Resistance 04/2022 - 01/2006
6	Chronic Hepatitis B 01/2022 - 08/2013
6	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2017
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2017 - 03/2012
5	Non-alcoholic Fatty Liver Disease 04/2022 - 01/2019
5	Hyperplasia 01/2021 - 06/2014
5	Hypercholesterolemia 08/2017 - 10/2006
5	Hypoxia (Hypoxemia) 01/2016 - 06/2007
5	Ischemia 01/2013 - 07/2005
4	Atherosclerosis 09/2021 - 11/2012
4	Rheumatoid Arthritis 08/2021 - 01/2008
4	Atrial Fibrillation 01/2021 - 01/2012
4	Coronary Disease (Coronary Heart Disease) 01/2018 - 07/2007
4	Essential Hypertension 02/2012 - 10/2006
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2012
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 11/2014
3	Pulmonary Hypertension 01/2022 - 01/2017
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2019
3	Arteriosclerosis 01/2020 - 06/2014
3	Carcinogenesis 01/2020 - 04/2011
3	Pain (Aches) 01/2020 - 01/2018
3	Carotid Artery Diseases 09/2019 - 07/2014
3	Stroke (Strokes) 05/2019 - 07/2007
3	Neointima 01/2019 - 01/2016
3	Diabetes Mellitus 01/2017 - 07/2012
3	Carcinoma (Carcinomatosis) 01/2015 - 01/2011
3	Myocardial Ischemia (Ischemic Heart Diseases) 02/2014 - 03/2012
3	Obesity 01/2013 - 06/2005
3	Necrosis 01/2012 - 02/2002
3	Body Weight (Weight, Body) 12/2008 - 02/2005
2	Acute Coronary Syndrome 12/2022 - 03/2013

Drug/Important Bio-Agent (IBA)

19	LipidsIBA 04/2022 - 10/2006
12	oxidized low density lipoproteinIBA 05/2022 - 06/2003
12	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2002
11	Angiotensin IIIBA 01/2021 - 02/2005
10	CytokinesIBA 01/2020 - 03/2003
10	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 10/2012
8	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 04/2012
8	HomocysteineIBA 01/2021 - 01/2008
8	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 01/2013
8	Blood Glucose (Blood Sugar)IBA 10/2020 - 07/2012
8	PPAR gammaIBA 02/2014 - 12/2004
7	Messenger RNA (mRNA)IBA 01/2022 - 02/2005
7	Pharmaceutical PreparationsIBA 08/2021 - 02/2003
7	HDL CholesterolIBA 01/2021 - 10/2011
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 10/2005
7	MicroRNAs (MicroRNA)IBA 01/2020 - 07/2011
7	Pioglitazone (Actos)FDA Link 02/2014 - 02/2005
6	xuezhikangIBA 01/2021 - 10/2006
6	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2014
6	Biomarkers (Surrogate Marker)IBA 10/2020 - 05/2004
6	LDL CholesterolIBA 09/2019 - 01/2014
6	Insulin-Like Growth Factor I (IGF-1)IBA 01/2013 - 11/2004
5	LipopolysaccharidesIBA 01/2021 - 05/2012
5	CholesterolIBA 01/2019 - 01/2016
5	Troponin T (Troponin T1)IBA 01/2017 - 01/2012
5	Atorvastatin (Lipitor)FDA Link 12/2015 - 12/2005
5	PPAR alphaIBA 10/2010 - 12/2004
4	Dual-Specificity PhosphatasesIBA 01/2021 - 01/2019
4	CreatinineIBA 01/2021 - 11/2010
4	Hepatitis B e AntigensIBA 01/2020 - 01/2014
3	Uric Acid (Urate)IBA 11/2021 - 01/2014
3	C-Reactive ProteinIBA 01/2021 - 01/2014
3	Serum AlbuminIBA 01/2021 - 12/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 03/2003
3	Antiviral Agents (Antivirals)IBA 01/2020 - 04/2004
3	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 01/2012
3	EnzymesIBA 01/2020 - 10/2019
3	InflammasomesIBA 01/2020 - 12/2014
3	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2013
3	Rosuvastatin Calcium (Crestor)FDA Link 09/2019 - 11/2012
3	Insulin (Novolin)FDA Link 01/2019 - 06/2007
3	AldosteroneIBA 01/2018 - 10/2007
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2016 - 09/2013
3	HDL LipoproteinsIBA 01/2016 - 10/2011
3	Complementary DNA (cDNA)IBA 01/2015 - 03/2002
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2013 - 02/2008
2	Cyclin D1IBA 01/2022 - 05/2007
2	CateninsIBA 01/2022 - 01/2018
2	LigandsIBA 01/2022 - 11/2011

Therapy/Procedure

26	Therapeutics 08/2021 - 03/2003
4	Ligation 01/2017 - 02/2005
3	Renal Dialysis (Hemodialysis) 01/2022 - 01/2013
3	Transplantation 01/2020 - 05/2013